Increase efficiency in B cell workflows for clinical and biotherapeutic research and antibody development

In this application note, Sartorius addresses challenges in B cell workflows and highlights the drawbacks of traditional hybridoma methods, such as being time-consuming, costly, and inefficient. Sartorius proposes solutions to improve efficiency and performance by characterizing B cells earlier in the hybridoma development workflow. This approach aims to enhance the robustness of B cells, minimizing potential pitfalls in the development of therapeutic antibodies.